As of 2024-12-12, the EV/EBITDA ratio of Redx Pharma PLC (REDX.L) is -1.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. REDX.L's latest enterprise value is 38.49 mil GBP. REDX.L's TTM EBITDA according to its financial statements is -30.02 mil GBP. Dividing these 2 quantities gives us the above REDX.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 6.4x | 5.9x |
| Forward P/E multiples | 7.1x - 12.2x | 8.8x |
| Fair Price | (81.80) - (73.70) | (84.93) |
| Upside | -645.3% - -591.3% | -666.2% |
| Date | EV/EBITDA |